Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SAXAGLIPTIN vs SCOPOLAMINE HYDROBROMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SAXAGLIPTIN vs SCOPOLAMINE HYDROBROMIDE: Safety Overview

Metric SAXAGLIPTIN SCOPOLAMINE HYDROBROMIDE
Total FAERS Reports 2,468 298
Deaths Reported 263 50
Death Rate 10.7% 16.8%
Hospitalizations 838 91
Average Patient Age 65.5 yrs 48.5 yrs
% Female Patients 47.8% 67.7%
FDA Approval Date Jul 31, 2009 N/A
Manufacturer Glenmark Pharmaceuticals Inc., USA N/A
Route ORAL N/A
Marketing Status Discontinued N/A